Per Ejlstrup Sigvardsen

Per Ejlstrup Sigvardsen

Auto-generated profile, based on publicly available information

Per Ejlstrup Sigvardsen

Department of Cardiology, The Heart Center, Copenhagen University Hospital—Rigshospitalet , Copenhagen

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2023 in Annals of Internal Medicine
Verified
Journal Article
Closed access
AFAndreas Fuchs
Andreas Fuchs
JKJørgen Tobias Kühl
Jørgen Tobias Kühl
PSPer Ejlstrup Sigvardsen
Per Ejlstrup Sigvardsen
SAShoaib Afzal
Shoaib Afzal
AKAndreas Dehlbæk Knudsen
Andreas Dehlbæk Knudsen
KKKlaus Fuglsang Kofoed
Klaus Fuglsang Kofoed
Coronary atherosclerosis may develop at an early age and remain latent for many years. To define characteristics of subclinical coronary atherosclerosis associated with the development of myocardial infarction. Prospective observational cohort study. Copenhagen General Population Study, Denmark. 9533 asymptomatic persons aged 40 years or older without known ischemic heart disease. Subclinical coronary atherosclerosis was assessed with coronary computed tomography angiography conducted blinded to treatment and outcomes. Coronary atherosclerosis was characterized according to luminal obstruction (nonobstructive or obstructive [≥50% luminal stenosis]) and extent (nonextensive or extensive [one third or more of the coronary tree]). The primary outcome was myocardial infarction, and the secondary outcome was a composite of death or myocardial infarction. A total of 5114 (54%) persons had no subclinical coronary atherosclerosis, 3483 (36%) had nonobstructive disease, and 936 (10%) had obstructive disease. Within a median follow-up of 3.5 years (range, 0.1 to 8.9 years), 193 persons died and 71 had myocardial infarction. The risk for myocardial infarction was increased in persons with obstructive (adjusted relative risk, 9.19 [95% CI, 4.49 to 18.11]) and extensive (7.65 [CI, 3.53 to 16.57]) disease. The highest risk for myocardial infarction was noted in persons with obstructive-extensive subclinical coronary atherosclerosis (adjusted relative risk, 12.48 [CI, 5.50 to 28.12]) or obstructive-nonextensive (adjusted relative risk, 8.28 [CI, 3.75 to 18.32]). The risk for the composite end point of death or myocardial infarction was increased in persons with extensive disease, regardless of degree of obstruction-for example, nonobstructive-extensive (adjusted relative risk, 2.70 [CI, 1.72 to 4.25]) and obstructive-extensive (adjusted relative risk, 3.15 [CI, 2.05 to 4.83]). Mostly White persons were studied. In asymptomatic persons, subclinical, obstructive coronary atherosclerosis is associated with a more than 8-fold elevated risk for myocardial infarction. AP Møller og Hustru Chastine Mc-Kinney Møllers Fond.

25 April 2024 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
MPMichael Huy Cuong Pham
Michael Huy Cuong Pham
PSPer Ejlstrup Sigvardsen
Per Ejlstrup Sigvardsen
AFAndreas Fuchs
Andreas Fuchs
JKJørgen Tobias Kühl
Jørgen Tobias Kühl
HSHenrik Sillesen
Henrik Sillesen
KKKlaus Fuglsang Kofoed
Klaus Fuglsang Kofoed
The prevalence and difference in risk factors for having thoracic aortic aneurysm (TAA) and abdominal aortic aneurysm (AAA) in men compared with women in the general population is not well described. This study aimed to test the hypotheses that (i) cardiovascular risk factors for TAA and AAA differ and (ii) the prevalence of TAA and AAA is sex specific. Aortic examination using computed tomography angiography was performed in 11 294 individuals (56% women), with a mean age of 62 (range 40–95) years participating in the Copenhagen General Population Study. TAAs were defined as an ascending aortic diameter ≥45 mm and a descending aortic diameter ≥35 mm, while AAAs were defined as an abdominal aortic diameter ≥30 mm. Demographic data were obtained from questionnaires. Overall prevalence of aortic aneurysms (AAs) in the study population included: total population 2.1%, men 4.0% and women 0.7% (P-value men vs. women P < 0.001). AAs were independently associated with male sex, increasing age, and body surface area (BSA). While TAAs were associated with hypertension, odds ratio (OR) = 2.0 [95% confidence interval (CI): 1.5–2.8], AAAs were associated with hypercholesterolaemia and smoking, OR = 2.4 (95% CI: 1.6–3.6) and 3.2 (95% CI: 1.9–5.4). Subclinical AAs are four times more prevalent in men than in women. In both sexes, increasing age and BSA are risk factors for AAs of any anatomical location. Whereas arterial hypertension is a risk factor for TAAs, hypercholesterolaemia and smoking are risk factors for AAAs. Risk factors for and prevalence of thoracic aortic aneurysm and abdominal aortic aneurysm (AAA). The width of risk factor bars at each aortic location represents the odds ratio for ascending aortic aneurysm (AA), descending AA, and AAA. The right side of the illustration depicts the different AA locations and the prevalence stratified by sex.

1 May 2022 in Atherosclerosis
Verified
Journal Article
Open access
MKMorten Kaltoft
Morten Kaltoft
PSPer E. Sigvardsen
Per E. Sigvardsen
SAShoaib Afzal
Shoaib Afzal
ALAnne Langsted
Anne Langsted
AFAndreas Fuchs
Andreas Fuchs
BNBørge G. Nordestgaard
Børge G. Nordestgaard
We tested the hypotheses (i) that elevated lipoprotein(a) is causally associated with both mitral and aortic valve calcification and disease, and (ii) that aortic valve calcification mediates the effect of elevated lipoprotein(a) on aortic valve stenosis. From the Copenhagen General Population study, we included 12,006 individuals who underwent cardiac computed tomography to measure mitral and aortic valve calcification and 85,884 to examine risk of heart valve disease. Participants had information on plasma lipoprotein(a) and genetic instruments associated with plasma lipoprotein(a) to investigate potential causality. At age 70-79 years, 29% and 54% had mitral and aortic valve calcification, respectively. For 10-fold higher lipoprotein(a) levels, multifactorially adjusted odds ratios for mitral and aortic valve calcification were 1.26 (95% confidence interval: 1.13-1.41) and 1.62 (1.48-1.77). For mitral and aortic valve stenosis, corresponding hazard ratios were 0.93 (95%CI:0.40-2.15, 19 events) and 1.54 (1.38-1.71, 1158 events), respectively. For ≤23 versus ≥36 kringle IV type 2 number of repeats, the age and sex adjusted odds ratios for mitral and aortic valve calcification were 1.53 (1.18-1.99) and 2.23 (1.81-2.76). For carriers versus non-carriers of LPA rs10455872, odds ratios for mitral and aortic valve calcification were 1.33 (1.13-1.57) and 1.86 (1.64-2.13). For aortic valve stenosis, 31% (95%CI:16%-76%) of the effect of lipoprotein(a) was mediated through calcification. Elevated lipoprotein(a) was genetically and observationally associated with mitral and aortic valve calcification and aortic valve stenosis. Aortic valve calcification mediated 31% of the effect of elevated lipoprotein(a) on aortic valve stenosis.

9 May 2020 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Closed access
PSPer E Sigvardsen
Per E Sigvardsen
AFAndreas Fuchs
Andreas Fuchs
JKJørgen T Kühl
Jørgen T Kühl
SAShoaib Afzal
Shoaib Afzal
LKLars Køber
Lars Køber
KKKlaus F Kofoed
Klaus F Kofoed
Aims : Prominent left ventricular trabeculations is a phenotypic trait observed in cardiovascular diseases. In the general population, the extent of left ventricular trabeculations is highly variable, yet it is unknown whether increased trabeculation is associated with adverse outcome. Methods and results : Left ventricular trabeculated mass (g/m2) was measured with contrast-enhanced cardiac computed tomography in 10 097 individuals from the Copenhagen General Population Study. The primary endpoint was a composite of major adverse cardiovascular events and defined as death, heart failure, myocardial infarction, or stroke. The secondary endpoints were the individual components of the primary endpoint. Cox regression models were adjusted for clinical parameters, medical history, electrocardiographic parameters, and cardiac chamber sizes. The mean trabeculated mass was 19.1 g/m2 (standard deviation 4.9 g/m2). During a median follow-up of 4.0 years (interquartile range 1.5–6.7), 710 major adverse cardiovascular events occurred in 619 individuals. Individuals with a left ventricular trabeculated mass in the highest quartile had a hazard ratio for major adverse cardiovascular events of 1.64 [95% confidence interval (CI) 1.30–2.08; P < 0.001] compared to those in the lowest quartile. Corresponding hazard ratios were 2.08 (95% CI 1.38–3.14; P < 0.001) for death, 2.63 (95% CI 1.61–4.31; P < 0.001) for heart failure, 1.08 (95% CI 0.56–2.08; P = 0.82) for myocardial infarction, and 1.07 (95% CI 0.72–1.57; P = 0.74) for stroke. Conclusion : Increased left ventricular trabeculation is independently associated with an increased rate of major adverse cardiovascular events in the general population.

31 July 2025 in European Heart Journal
Verified
Journal Article
Closed access
JPJonas Jalili Pedersen
Jonas Jalili Pedersen
JKJørgen Tobias Kühl
Jørgen Tobias Kühl
MEMarie Bayer Elming
Marie Bayer Elming
MPMichael Huy Cuong Pham
Michael Huy Cuong Pham
PSPer Ejlstrup Sigvardsen
Per Ejlstrup Sigvardsen
KKKlaus Fuglsang Kofoed
Klaus Fuglsang Kofoed

21 February 2020 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Closed access
PSPer E Sigvardsen
Per E Sigvardsen
MPMichael H C Pham
Michael H C Pham
JKJørgen T Kühl
Jørgen T Kühl
AFAndreas Fuchs
Andreas Fuchs
SAShoaib Afzal
Shoaib Afzal
KKKlaus F Kofoed
Klaus F Kofoed
Aims : Left ventricular (LV) myocardial crypts are considered a subtle marker of hypertrophic cardiomyopathy. However, crypts have also been observed in seemingly healthy individuals and it is unknown whether myocardial crypts are associated with adverse outcome. Methods and results : Myocardial crypts were defined as invaginations traversing >50% of the myocardial wall and assessed using contrast-enhanced cardiac computed tomography in 10 097 individuals from the Copenhagen General Population Study. Number of crypts, location, shape, penetrance, and volume were assessed. The endpoint was a composite of major adverse cardiovascular events and defined as death, myocardial infarction, heart failure, or stroke. Cox regression models were adjusted for clinical variables, medical history, electrocardiographic parameters, and cardiac chamber sizes. A total of 1199 LV myocardial crypts were identified in 915 (9.1%) individuals. Seven hundred (6.9%) had one crypt and 215 (2.1%) had multiple crypts. During a median follow-up of 4.0 years (interquartile range 1.5–6.7), major adverse cardiovascular events occurred in 619 individuals. Individuals with one or multiple crypts had a hazard ratio for major adverse cardiovascular events of 1.00 [95% confidence interval (CI): 0.72–1.40; P = 0.98] and 0.90 (95% CI: 0.47–1.75; P = 0.76), respectively, compared with those with no crypts. No specific pattern of crypt location, shape, penetrance, or volume was associated to an increased hazard ratio for major adverse cardiovascular events. Conclusion : LV myocardial crypts are frequent in the general population and are not associated with intermediate-term major adverse cardiovascular events.